|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00570 TRAD CHI MED
Nominal 
2.310 +0.030 (+1.316%) | 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | |
| Turnover | 8,385,473 | -9.862% | 9,302,957 | 5,911,638 | 8,149,351 | 6,655,319 |
| Cost of Sales | (4,324,219) | -4.857% | (4,544,981) | (2,959,767) | (3,146,587) | (2,638,465) |
| Gross Profit | 4,061,254 | -14.643% | 4,757,976 | 2,951,871 | 5,002,764 | 4,016,854 |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (158,768) | 232.373% | (47,768) | (36,935) | (46,280) | (33,139) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (874) | -51.336% | (1,796) | (1,640) | (7,808) | (4,860) | |
| Profit / (Loss) before Taxation | 299,434 | -57.636% | 706,812 | 469,766 | 1,197,923 | 990,371 | |
| Taxation | (85,291) | -5.076% | (89,852) | (48,231) | (191,244) | (160,174) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (3,164) | -91.721% | (38,218) | (7,947) | (76,851) | (98,177) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 210,979 | -63.545% | 578,742 | 413,588 | 929,828 | 732,020 | |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | |
| Net Finance Costs / (Income) | 67,954 | -8.340% | 74,137 | 71,568 | 85,575 | 90,843 |
| Depreciation & Amortisation | 561,477 | -1.004% | 567,170 | 543,874 | 389,863 | 324,520 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| EPS (cts) | 4.190 | -63.534% | 11.490 | 8.210 | 18.460 | 14.540 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 5.540 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | 30.011% | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 4.244 | -- | 4.073 | 3.933 | 3.772 | 3.404 |
| Remarks: | Real time quote last updated: 24/12/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 210,979 |
| %Change | -63.545% |
| EPS / (LPS) | RMB 0.042 |
| NBV Per Share (¥) | RMB 4.244 |